Create a free account or log in.
ImmuPharma is an AIM-listed biopharmaceutical company developing peptide-based therapies for autoimmune diseases and anti-infectives.Ê Its lead program, P140, is in Phase 3 trials for SLE.Ê The company aims to build a robust pipeline through strategic partnerships and licensing, maximizing shareholder value.
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
213800TMDNIE3Z8XXD26
ABVX
Sector
Health Care
Country
France
ISIN
FR0012333284
Founded
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …
ADXN
Sector
Health Care
Country
Switzerland
ISIN
CH0029850754
Founded
2002
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …
AEGIR
Sector
Health Care
Country
Sweden
ISIN
SE0014401121
Founded
2019
AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …
ANIC
Sector
Health Care
Country
Isle of Man
ISIN
Founded
Allergy Therapeutics PLC: Global immunology leader, researching, developing, and manufacturing convenient allergy treatments.Ê Our mission: Transforming lives through innovative immunotherapy.
AIEA
Sector
Health Care
Country
United Kingdom
ISIN
Founded
Alliance Pharma PLC improves lives through clinically valuable healthcare products. We market consumer & prescription medicines, leveraging an asset-light model …
ALK
Sector
Health Care
Country
North Macedonia
ISIN
MKALKA101011
Founded
1936
Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …